Table 5. Previously reported outcomes with PD‐1 inhibitors in patients with R/R cHL.

Abbreviations: AutoSCT, autologous stem cell transplantation; BOR, best overall response; cHL, classical Hodgkin lymphoma; CR, complete response; ECOG PS, Eastern Cooperative Oncology Group performance status; LOT, line of therapy; NS, nodular sclerosing; ORR, overall response rate; OS, overall survival; PD, progressive disease; PD‐1, programmed death‐1; PFS, progression‐free survival; PR, partial response; R/R, relapsed or refractory; SD, stable disease.